Tejkamal Pharmaceuticals Private Limited

Tejkamal Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U24231KA2008PTC045112 Incorporated 30 January 2008 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2020
₹3.63 Lakh
▲ 355% YoY
Net profit · FY 2020
₹1.53 Lakh
Net margin 42.2%
EBITDA · FY 2020
-₹1.85 Lakh
EBITDA margin -50.9%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.5 Cr
Issued & subscribed
Satisfied charges
₹18.84 Cr
No open charges
Company age
18 yrs
Est. 2008
Employees · EPFO
32
Provident fund records

About Tejkamal Pharmaceuticals Private Limited

Data last updated:

Tejkamal Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 January 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA2008PTC045112. Its GSTIN is 29AACCT8428Q1ZG (Karnataka).

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.5 Cr. It is led by directors Deepa Jain and Vipin Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 012 D Block Platinum City Hmt Road Peenya Yashawanthpur, Bangalore, Karnataka, India – 560022.

As per the financials filed for FY 2020, the company reported a revenue of ₹3.63 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.53 Lakh (net margin 42.2%) and EBITDA of -₹1.85 Lakh (EBITDA margin -50.9%). Revenue has declined at a compounded annual rate (CAGR) of 87% over three years and 66% over five years.

The company has about 32 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹18.84 Cr on record. Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tejkamalpharma.com.

Company details

CIN U24231KA2008PTC045112
Registration Number 045112
Incorporation Date 30 January 2008
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Tejkamal Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is tejkamalpharma.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    No. 012 D Block Platinum City Hmt Road Peenya Yashawanthpur, Bangalore, Karnataka, India – 560022
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Tejkamal Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Tejkamal Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Tejkamal Pharmaceuticals Private Limited

FY 2025 filings available

Tejkamal Pharmaceuticals Private Limited reported revenue of ₹3.63 Lakh (up 355% YoY) for FY 2020.

Revenue · FY 2020
₹3.63 Lakh ▲ 355%
Net profit · FY 2020
₹1.53 Lakh margin 42.2%
EBITDA · FY 2020
-₹1.85 Lakh margin -50.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 355%
3 years · compounded
▼ 87%
5 years · compounded
▼ 66%

Revenue rose 355% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 66%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹3.63 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.85 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.53 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin-50.9%
Net Profit Margin42.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Tejkamal Pharmaceuticals Private Limited, buy the company report.

Board of directors of Tejkamal Pharmaceuticals Private Limited

Tejkamal Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Deepa JainDirector01 Feb 20215 Years 8 MonthsCurrent
Vipin KumarDirector30 Jan 200818 Years 8 MonthsCurrent

Auditor

Tejkamal Pharmaceuticals Private Limited is audited by S G BHAT & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
S G BHAT & COFY 2020000473S

Shareholding

The shareholding of Tejkamal Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2018FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Tejkamal Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹18.84 Cr
Breakdown by lending institutions
Canara Bank₹18.84 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Jan 201410476901Canara Bank₹7.5 LakhSatisfied
23 Oct 201310459692Canara Bank₹10 LakhSatisfied
02 Sep 200910204600Canara Bank₹18.66 CrSatisfied

To see the full charge records of Tejkamal Pharmaceuticals Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Tejkamal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Tejkamal Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AACCT8428Q1ZGKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Tejkamal Pharmaceuticals Private Limited, buy the company report.

Recent activity

Tejkamal Pharmaceuticals Private Limited has 4 board changes on record since 2008: 2 appointments and 2 cessations. The latest: Deepa Jain was appointed as Director on 01 Feb 2021.

AGM
Tejkamal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Tejkamal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Deepa Jain was appointed as Director.
Ceased
Rajiv Solanki ceased to be Director.
Ceased
Yatendra Kumar Kansal ceased to be Director.
Charges
A charge registered on 31 Jan 2014 via Charge ID 10476901 with Canara Bank was fully satisfied on 18 Aug 2016.
Charges
A charge registered on 23 Oct 2013 via Charge ID 10459692 with Canara Bank was fully satisfied on 18 Aug 2016.
Charges
A charge registered on 02 Sep 2009 via Charge ID 10204600 with Canara Bank was fully satisfied on 18 Aug 2016.
Charges
A charge with Canara Bank of Rs. 18.66 Cr registered on 02 Sep 2009 with Charge ID 10204600 was modified on 24 Jun 2015.
Charges
A charge with Canara Bank amounted to Rs. 0.08 Cr with Charge ID 10476901 was registered on 31 Jan 2014.
Charges
A charge with Canara Bank amounted to Rs. 0.10 Cr with Charge ID 10459692 was registered on 23 Oct 2013.
Charges
A charge with Canara Bank amounted to Rs. 18.66 Cr with Charge ID 10204600 was registered on 02 Sep 2009.

2 earlier events are in the company report.

Frequently asked questions

Tejkamal Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 January 2008 (18+ years old) and is registered under CIN U24231KA2008PTC045112.

Tejkamal Pharmaceuticals has 2 current directors:

The latest financial statements of Tejkamal Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Tejkamal Pharmaceuticals is 29AACCT8428Q1ZG, registered in Karnataka.

The CIN (Corporate Identification Number) of Tejkamal Pharmaceuticals is U24231KA2008PTC045112. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Tejkamal Pharmaceuticals has 6 court cases on record: 1 filed by the company and 5 filed against it. 1 is pending. Most are in the district courts.

Tejkamal Pharmaceuticals was incorporated on 30 January 2008, making it 18+ years old. It is registered with the Registrar of Companies, Bangalore.

Deepa Jain was appointed as Director on 01 Feb 2021. Rajiv Solanki ceased to be Director on 01 Feb 2021. Yatendra Kumar Kansal ceased to be Director on 11 Jan 2017. Tejkamal Pharmaceuticals has 4 board changes on record in total.

Tejkamal Pharmaceuticals can be reached through the website tejkamalpharma.com. Its registered office is in Bangalore, Karnataka, India.

The registered office of Tejkamal Pharmaceuticals is at No. 012 D Block Platinum City Hmt Road Peenya Yashawanthpur, Bangalore, Karnataka, India – 560022.